coiling

卷取
  • 文章类型: Journal Article
    迟发性脑缺血(DCI)是动脉瘤性蛛网膜下腔出血(aSAH)最重要的预后决定因素之一。VASOGRADE,结合了世界神经外科医师联合会等级和改良的费舍尔等级,是预测aSAH后DCI的有用量表。然而,没有研究调查VASOGRADE是否影响治疗方案.我们回顾性分析了2013年至2021年在9个主要卒中中心前瞻性招募的781例aSAH患者。总队列包括76例(9.7%)VASOGRADE-Green患者,390例患者(49.9%)为VASOGRADE-Yellow,和315例患者(40.3%)的VASOGRADE-Red。更糟糕的VASOGRADE有更高的DCI发生率,发生在190例患者中(24.3%)。由于只有5例(6.6%)VASOGRADE-Green患者发生DCI,因此我们在VASOGRADE-黄色和-红色患者中搜索DCI相关因子。多因素分析显示抑制DCI的独立治疗因素如下:无术后出血并发症,联合使用盐酸法舒地尔和西洛他唑,夹闭和脑池引流相结合,和波浪形黄色卷取;和剪裁,和服用盐酸法舒地尔,有或没有西洛他唑的VASOGRADE-Red。研究结果表明,应根据VASOGRADE确定治疗策略,以预防aSAH后的DCI。
    Delayed cerebral ischemia (DCI) is one of the most important outcome determinants for aneurysmal subarachnoid hemorrhage (aSAH). VASOGRADE, which combines World Federation of Neurological Surgeons grade and modified Fisher grade, is a useful scale for predicting DCI after aSAH. However, no studies have investigated whether VASOGRADE influences the treatment options. We retrospectively analyzed 781 aSAH patients who were prospectively enrolled in 9 primary stroke centers from 2013 to 2021. The total cohort consisted of 76 patients (9.7%) with VASOGRADE-Green, 390 patients (49.9%) with VASOGRADE-Yellow, and 315 patients (40.3%) with VASOGRADE-Red. Worse VASOGRADE had higher incidences of DCI, which occurred in 190 patients (24.3%). As only 5 patients (6.6%) with VASOGRADE-Green developed DCI, we searched for DCI-associated factors in patients with VASOGRADEs-Yellow and -Red. Multivariate analyses revealed independent treatment factors suppressing DCI as follows: no postoperative hemorrhagic complication, combined administration of fasudil hydrochloride and cilostazol, combination of clipping and cisternal drainage, and coiling for VASOGRADE-Yellow; and clipping, and administration of fasudil hydrochloride with or without cilostazol for VASOGRADE-Red. The findings suggest that treatment strategies should be determined based on VASOGRADE to prevent DCI after aSAH.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    评估了经动脉放射栓塞(TARE)的介入治疗方法对肝外微球沉积和血管造影并发症发生率的影响。总的来说,分析了398个TARE周期。介入治疗方法分为单一治疗位置(TP)与介入闭塞(IO),多个没有IO的TP,和多个带IO的TP。与肝外微球沉积的相关性,血管造影并发症,并进行围手术期临床事件。评估了替代治疗策略。来自多个TP的应用可以确保微球在48.2%的情况下的安全应用,这些情况最初是在IO后从单个TP进行的。在5.2%后检测到肝外微球积累,5.3%,和1.5%的TARE程序来自没有IO的单个TP,具有IO的单个TP,和多个没有IO的TP,分别。多个TP的应用并未增加血管造影并发症。在30天的随访中,与无IO组相比,IO组的恶心/呕吐和上腹部不适发生率更高(7.9%/4.6%和9.2%/5.9%,分别)。在许多TARE程序中,可以从多个TP而不是单个TP治疗相同的目标肝脏,减少对异常动脉的介入闭塞和潜在的肝外微球沉积的需要。
    The influence of the interventional treatment approach for transarterial radioembolization (TARE) on the incidence of extrahepatic microsphere depositions and to angiographic complications was evaluated. In total, 398 TARE cycles were analyzed. Interventional treatment approaches were classified as single treatment position (TP) with interventional occlusion (IO), multiple TPs without IO, and multiple TPs with IO. Correlations with extrahepatic microsphere depositions, angiographic complications, and periprocedural clinical events were performed. Alternative treatment strategies were evaluated. Applications from multiple TPs could have ensured the safe application of microspheres in 48.2% of cases that were originally performed from a single TP after IO. Extrahepatic microsphere accumulations were detected after 5.2%, 5.3%, and 1.5% of TARE procedures from a single TP without IO, a single TP with IO, and multiple TPs without IO, respectively. Applications from multiple TPs did not increase angiographic complications. During the 30-day follow-up, nausea/vomiting and upper abdominal discomfort were observed more frequently in the group with IO than in the group without IO (7.9%/4.6% and 9.2%/5.9%, respectively). In many TARE procedures, the same target liver can be treated from multiple TPs instead of a single TP, reducing the need for the interventional occlusion of aberrant arteries and potential extrahepatic microsphere depositions.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    在前循环动脉瘤性蛛网膜下腔出血(aSAH)患者中,目前,血管内卷绕比神经外科夹闭更频繁。然而,尽管之前有多项研究,就长期临床结局而言,卷绕是否有利仍不确定.
    夹闭与卷绕对aSAH患者的长期功能结局有何影响?
    在荷兰两家医院接受夹闭或卷绕治疗的所有前循环aSAH患者(2012-2015)在治疗后长达五年进行了研究。功能结果,生存,测量了患者的复发率和并发症发生率。两组均进行生存分析。使用协变量校正的多变量回归模型来研究不利结果的可能性(改良的Rankin量表>2)。
    在204名患者中,75例患者被夹住(37%),129例接受卷取(63%)。与剪裁相比,卷取的再治疗率更高(7.8%vs.0.0%)。六点不利的结果,治疗后12、24和60个月的患者在夹闭后比卷取高,但在校正WFNS分级所代表的临床严重程度后并不显著.60个月后,剪裁和卷取之间的存活率没有差异。
    在这项研究中没有发现剪裁和卷绕在生存和长期功能结果方面的差异。需要进行更多的前瞻性设计和大型队列研究,以确定两种治疗方法之间可能的差异。
    UNASSIGNED: In patients with anterior circulation aneurysmal Subarachnoid Haemorrhage (aSAH), endovascular coiling is currently practiced more frequently than neurosurgical clipping. However, despite multiple previous studies, it is still uncertain whether coiling is favourable in terms of long-term clinical outcome.
    UNASSIGNED: What is the effect of clipping versus coiling on long-term functional outcome of patients with an aSAH?
    UNASSIGNED: All anterior circulation aSAH patients (2012-2015) treated with clipping or coiling in two hospitals in the Netherlands were studied up to five years after treatment. Functional outcome, survival, retreatment- and complication rate were measured. Survival analysis was performed in both groups. A multivariable regression model with covariate adjustment was performed to investigate the likelihood of unfavourable outcome (modified Rankin Scale >2).
    UNASSIGNED: Out of 204 patients, 75 patients were clipped (37%) and 129 received coiling (63%). Coiling had a higher retreatment rate compared to clipping (7.8% vs. 0.0%). Unfavourable outcome at six, 12, 24 and 60 months after treatment was higher for patients after clipping compared to coiling, but was not significant after correcting for clinical severity as represented by the WFNS grade. In 60 months, no difference in survival was found between clipping and coiling.
    UNASSIGNED: No differences between clipping and coiling in survival and long-term functional outcome have been found in this study. More research with prospective design and large cohorts is needed to identify possible differences between the two treatments.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    暂无摘要。
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    破裂的腹主动脉瘤(rAAAs)危及生命,需要紧急手术治疗。血管内主动脉破裂修复术(rEVAR)由于其微创方法具有较低的发病率和死亡率,已成为主要策略。尤其是出现血流动力学不稳定和相关合并症的患者。在rEVAR之后,术中血管造影或早期介入后计算机断层扫描血管造影必须排除需要立即再介入的早期1型或3型内漏.rEVAR后持续的2型内漏(T2ELs),与选修案件相比,由于通过剩余的主动脉瘤破裂部位持续的血管外失血,可能导致致命的情况。因此,在rEVAR后的急性术后设置中,必须早期识别与持续出血和血流动力学不稳定相关的持续性T2ELs,并立即进行治疗.rEVAR后T2EL遮挡的不同技术和概念可用,大多数也用于选择性EVAR后的相关T2EL。除了针对持续性T2EL的各种介入栓塞手术外,一些患者需要开放手术阻断T2EL供血动脉,rEVAR后动脉瘤破裂部位的腹腔减压或直接手术补片闭塞。到目前为止,在rAAAs的严峻形势下,尚未确定rEVAR期间先发制人或术中T2EL栓塞的指征.从长远来看,rEVAR后持续的T2ELs可导致动脉瘤持续扩张,并可能出现继发性近端I型内漏,再破裂的风险增加,需要定期随访和早期考虑再干预.迄今为止,只有极少数研究对rEVAR后的T2ELs进行了调查,或将结果与选择性EVAR中的T2ELs持续性的特殊方面进行了比较.这篇叙述性综述旨在介绍目前关于发病率的知识,自然史,rEVAR后T2EL管理的相关性和策略。
    Ruptured abdominal aortic aneurysms (rAAAs) are life-threatening and require emergent surgical therapy. Endovascular aortic repair for rupture (rEVAR) has become the leading strategy due to its minimal invasive approach with expected lower morbidity and mortality, especially in patients presenting with hemodynamic instability and relevant comorbidities. Following rEVAR, intraoperative angiography or early postinterventional computed tomography angiography have to exclude early type 1 or 3 endoleaks requiring immediate reintervention. Persistent type 2 endoleaks (T2ELs) after rEVAR, in contrast to elective cases, can cause possibly lethal situations due to continuing extravascular blood loss through the remaining aortic aneurysm rupture site. Therefore, early identification of relevant persistent T2ELs associated with continuous bleeding and hemodynamic instability and immediate management is mandatory in the acute postoperative setting following rEVAR. Different techniques and concepts for the occlusion of T2ELs after rEVAR are available, and most of them are also used for relevant T2ELs after elective EVAR. In addition to various interventional embolization procedures for persistent T2ELs, some patients require open surgical occlusion of T2EL-feeding arteries, abdominal compartment decompression or direct surgical patch occlusion of the aneurysm rupture site after rEVAR. So far, in the acute situation of rAAAs, indications for preemptive or intraoperative T2EL embolization during rEVAR have not been established. In the long term, persistent T2ELs after rEVAR can lead to continuous aneurysm expansion with the possible development of secondary proximal type I endoleaks and an increased risk of re-rupture requiring regular follow-up and early consideration for reintervention. To date, only very few studies have investigated T2ELs after rEVAR or compared outcomes with those from elective EVAR regarding the special aspects of persisting T2ELs. This narrative review is intended to present the current knowledge on the incidence, natural history, relevance and strategies for T2EL management after rEVAR.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    使用各种技术和新设备治疗宽颈分叉脑动脉瘤(WNBAs)已显示出良好的结果。然而,当动脉瘤颈被合并到母体血管中时,血管内盘绕技术上具有挑战性.此外,尽管最近的研究报道了NeuroformAtlas支架(NAS)辅助卷绕的良好结果,广泛的纳入标准阻碍了对其治疗复杂WNBA的有效性和安全性的精确评估。因此,这项研究评估了使用单一NAS是否是治疗复杂WNBAs的安全有效方法。
    我们治疗了76例复杂的WNBAs(未破裂,n=49;破裂,n=27)使用单一NAS辅助线圈栓塞,并回顾性分析临床和血管造影结果。
    在68名患者的队列中(平均年龄,58.3±11.6岁;男性n=20,29.4%;女性,n=48,70.6%),76个支架成功输送到目标动脉瘤,技术成功率为98.6%。76个动脉瘤中有59个(77.6%)出现完全闭塞,颈部残留16例(21.1%),部分闭塞1例(1.3%)。治疗相关的发病率包括一个分支闭塞和一个实质出血。然而,出院时未出现未破裂动脉瘤的新神经系统症状.在最终随访评估(平均12.2[6-29]个月)时,27个破裂动脉瘤中的20个预后良好(格拉斯哥预后量表评分为4或5分)。除了一次蛛网膜下腔出血.治疗后血管造影显示89.1%完全闭塞,颈部残留物占7.8%,3.1%的动脉瘤不完全闭塞。大约88.2%的患者至少通过随访诊断或磁共振血管造影进行了一次评估(平均,12.5±4.3[范围,6-29个月),有5次(7.8%)轻微复发和2次(3.1%)主要复发。
    单个NAS对于治疗掺入母体血管的WNBAs是安全有效的。
    UNASSIGNED: Treating wide-neck bifurcated cerebral aneurysms (WNBAs) using various techniques and new devices has shown favorable outcomes. However, endovascular coiling can be technically challenging when the aneurysm neck is incorporated into the parent vessel. Furthermore, although recent research has reported favorable outcomes of Neuroform Atlas stent (NAS)-assisted coiling, broad inclusion criteria have hampered precise evaluations of their effectiveness and safety for treating complex WNBAs. Therefore, this study evaluated whether the use of a single NAS is a safe and effective approach for treating complex WNBAs.
    UNASSIGNED: We treated 76 complex WNBAs (unruptured, n = 49; ruptured, n = 27) using single NAS-assisted coil embolization and retrospectively analyzed the clinical and angiographic outcomes.
    UNASSIGNED: In a cohort of 68 patients (mean age, 58.3 ± 11.6 years; males n = 20, 29.4%; females, n = 48, 70.6%), 76 stents were successfully delivered to the target aneurysms, yielding a technical success rate of 98.6%. Complete occlusion was evident in 59 (77.6%) of 76 aneurysms, with neck remnants found in 16 (21.1%) and partial occlusion in 1 (1.3%). Treatment-related morbidities comprised one branch occlusion and one parenchymal hemorrhage. However, no new neurological symptoms of unruptured aneurysms were evident at discharge. The outcomes of 20 of the 27 ruptured aneurysms were favorable (Glasgow Outcome Scale scores of 4 or 5) at the final follow-up assessment (mean 12.2 [6-29] months), except for one initial subarachnoid hemorrhage. Post-treatment angiography revealed complete occlusion in 89.1%, neck remnants in 7.8%, and incomplete occlusion in 3.1% of the aneurysms. Approximately 88.2% of the patients were assessed at least once by follow-up diagnostic or magnetic resonance angiography (mean, 12.5 ± 4.3 [range, 6-29] months), with five (7.8%) minor and two (3.1%) major recurrences.
    UNASSIGNED: A single NAS is safe and effective for treating WNBAs incorporated into parent vessels.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    目的:研究临床特征和治疗选择与功能结局的关系,死亡率,和死亡时间在动脉瘤性蛛网膜下腔出血(aSAH)患者的国家样本中。
    方法:数据来自2014年9月至2018年3月进行的一项前瞻性全国多中心研究。格拉斯哥结果量表扩展(GOSE)等级,1年死亡率,和生存概率在一年后评估。Logistic单变量,多变量,和Cox回归分析用于研究变量与结局的关联。
    结果:在35.4%的患者中观察到不利的二分GOSE(dGOSE;1-4级)。大脑中动脉动脉瘤和Fisher4级首选显微外科手术。治疗方式与任何结果指标无关。二分法世界神经外科学会联合会(dWFNS),年龄,在多因素回归分析中,迟发性缺血性神经功能缺损(DIND)与dGOSE和1年死亡率显著相关.瞳孔扩张与1年死亡率结局相关。Cox回归分析显示瞳孔扩张的生存概率较低(风险比(HR)3.546),差费(HR3.688),年龄较高(HR1.051),和DIND发生(HR2.214)。
    结论:在瑞典,aSAH后的患者选择显示dGOSE值相似,1年死亡率,以及接受显微外科手术或血管内技术治疗的患者之间的生存概率。可怜的dWFNS,年龄较高,DIND与不良dGOSE显著相关,死亡率,和生存概率。瞳孔扩张与死亡率和生存概率显著相关。
    OBJECTIVE: To study associations of clinical characteristics and treatment choice with functional outcome, mortality, and time to death in a national sample of aneurysmal subarachnoidal hemorrhage patients.
    METHODS: Data were extracted from a prospective nationwide multicenter study performed in September 2014 to March 2018. Glasgow Outcome Scale Extended (GOSE) grade, 1-year mortality, and survival probability were assessed at one year after ictus. Logistic univariate, multivariate, and Cox regression analyses were used to study the variables\' associations with the outcomes.
    RESULTS: Unfavorable dichotomized GOSE (dGOSE; grades 1-4) was observed in 35.4% of patients. Microsurgery was preferred for middle cerebral artery aneurysms and Fisher grade 4. Treatment modality was not associated with any outcome measure. Dichotomized World Federation of Neurosurgical Societies (dWFNS), age, and delayed ischemic neurological deficit (DIND) showed significant correlations with dGOSE and 1-year mortality in multivariate regression analyses. Pupil dilatation was associated with a 1-year mortality outcome. Cox regression analysis showed lower survival probability for pupil dilatation (hazard ratio [HR]: 3.546), poor dWFNS (HR: 3.688), higher age (HR: 1.051), and DIND occurrence (HR: 2.214).
    CONCLUSIONS: The patient selection in Sweden after aneurysmal subarachnoidal hemorrhage showed similar values for dGOSE, 1-year mortality, and survival probability between patients treated with microsurgery or endovascular technique. Poor dWFNS, higher age, and DIND were significantly associated with unfavorable dGOSE, mortality, and survival probability. Pupil dilatation was significantly associated with mortality and survival probability.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    背景:蛛网膜囊肿是脑脊液充盈的间隙,通常是先天性的,保守治疗或有症状时开窗治疗。由于囊壁或囊肿腔内脆弱的软脑膜血管或静脉,在蛛网膜囊肿的存在下可出现慢性硬膜下血肿(cSDH)。导致出血和随后的血肿形成。脑膜中动脉(MMA)栓塞术通常用于治疗cSDH,以替代开颅手术和疏散术。
    方法:这里,作者介绍了成人MMA栓塞后蛛网膜囊肿和cSDH同时消退的第一份已知报告。一名24岁的男性出现在急诊科,头痛恶化1个月。影像学显示存在cSDH和同侧蛛网膜囊肿。仅使用线圈用MMA栓塞治疗cSDH。栓塞后4个月的随访成像显示血肿和蛛网膜囊肿同时消退。
    结论:MMA栓塞已用于治疗cSDH。如果血肿与蛛网膜囊肿有关,MMA栓塞还可以导致两种病理的同时解决。https://thejns.org/doi/10.3171/CASE24192。
    BACKGROUND: Arachnoid cysts are cerebrospinal fluid-filled spaces that are typically congenital and treated conservatively or with fenestration when symptomatic. Chronic subdural hematomas (cSDHs) can arise in the presence of arachnoid cysts due to fragile leptomeningeal vessels or veins within the cyst wall or cyst lumen, leading to bleeding and subsequent hematoma formation. Middle meningeal artery (MMA) embolization is regularly used for the treatment of cSDH as an alternative to craniotomy and evacuation.
    METHODS: Here, the authors present the first known report of the simultaneous resolution of an arachnoid cyst and cSDH following MMA embolization in an adult. A 24-year-old male presented to the emergency department with 1 month of worsening headaches. Imaging revealed the presence of a cSDH and ipsilateral arachnoid cyst. The cSDH was treated with MMA embolization using coils exclusively. Follow-up imaging 4 months after embolization demonstrated simultaneous resolution of both the hematoma and the arachnoid cyst.
    CONCLUSIONS: MMA embolization has been used for the treatment of cSDH. In cases in which the hematoma is related to an arachnoid cyst, MMA embolization can also lead to the concurrent resolution of both pathologies. https://thejns.org/doi/10.3171/CASE24192.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    动脉瘤性蛛网膜下腔出血(aSAH)是一种罕见但破坏性的并发症,发病率和死亡率增加。目前尚不清楚怀孕期间和围产期发病率是否增加。然而,在妊娠晚期,脑动脉瘤破裂的发生率高于妊娠早期。全身麻醉或脊髓麻醉期间动脉瘤破裂和蛛网膜下腔出血(SAH)的风险尚不清楚。我们报告了一例在产后即刻进行低段剖腹产(LSCS)的脊髓麻醉后,左股上动脉瘤破裂,导致高度aSAH。
    Aneurysmal subarachnoid hemorrhage (aSAH) is a rare but devastating complication with increased morbidity and mortality. It is still unclear whether the incidence is increased during pregnancy and in the peripartum period. However, the incidence of cerebral aneurysmal rupture is higher during the third trimester than in the first trimester. The risk of aneurysmal rupture and subarachnoid hemorrhage (SAH) during general anesthesia or spinal anesthesia is unclear. We report a case of left supraclinoid aneurysm rupture after spinal anesthesia for Low Segment Caesarean Section (LSCS) in the immediate postpartum period causing high-grade aSAH.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:治疗基底尖动脉瘤(BAA)的血管内选择是异质的,证据仅限于回顾性队列和病例系列。我们试图评估与各种血管内治疗方法相关的BAA的疗效和并发症。
    方法:PubMed的系统评价,Embase,和WebofScience坚持PRISMA准则。纳入2010年1月至2024年7月期间评估BAA血管内治疗的回顾性和前瞻性研究。相关信息,包括闭塞率,动脉瘤复发,再治疗率,和并发症进行荟萃分析。
    结果:纳入了15项1,049个BAAs的研究。动脉瘤的中位直径为8.5mm(范围为4.6-19.75),中位随访时间为33.7个月(范围6.0-117.6)。在初次盘绕后,残留的动脉瘤充盈发生率为24%(95%CI=0.16-0.32),单支架辅助卷绕后25%(s-SAC;95%CI=0.04-0.46),Y型支架置入后25%(95%CI=0.12-0.37),分流支架置入后为23%(FDS;95%CI=0.11-0.35)。初次卷取的复发率很高(27%,95%CI=0.18-0.36)和s-SAC(19%,95%CI=0.13-0.26),但Y支架显著降低(9%,95%CI=0.03-0.15)和FDS(4%,95%CI=-0.04-0.11)。一次卷取的复治率为19%(95%CI=0.12-0.26),S-SAC为17%(95%CI=0.07-0.27),5%的Y支架(95%CI=-0.03-0.12),FDS为13%(95%CI=-0.01-0.27)。Meta回归显示较大的动脉瘤有较高的并发症发生率(p=0.02)。FDS和Y支架置入术中血栓栓塞事件最常见(12%)。
    结论:不同治疗组的闭塞率相似,但与原发性卷绕相比,Y型支架置入和FDS治疗后的复发率明显较低,尽管他们携带更多的血栓栓塞并发症。
    BACKGROUND: Endovascular options for the treatment of basilar apex aneurysms (BAAs) are heterogeneous, and evidence is limited to retrospective cohorts and case series. We seek to evaluate the efficacy and complications associated with various endovascular treatment methods of BAAs.
    METHODS: Systematic review of PubMed, Embase, and Web of Science adhering to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Retrospective and prospective studies evaluating endovascular treatment of BAAs between January 2010 and July 2024 were included. Relevant information including occlusion rates, aneurysm recurrence, retreatment rates, and complications were subjected to meta-analysis.
    RESULTS: Fifteen studies with 1049 BAAs were included. The median aneurysm diameter was 8.5 mm (range, 4.6-19.75), with a median follow-up of 33.7 months (range, 6.0-117.6). Residual aneurysm filling occurred in 24% after primary coiling (95% CI = 0.16-0.32), 25% after single stent-assisted coiling (s-SAC; 95% CI = 0.04-0.46), 25% after Y-stents (95% CI = 0.12-0.37), and 23% after flow diverter stent (FDS; 95% CI = 0.11-0.35). Recurrence rates were high for primary coiling (27%, 95% CI = 0.18-0.36) and s-SAC (19%, 95% CI = 0.13-0.26), but significantly lower for Y-stents (9%, 95% CI = 0.03-0.15) and FDS (4%, 95% CI = -0.04-0.11). Retreatment rates were 19% for primary coiling (95% CI = 0.12-0.26), 17% for s-SAC (95% CI = 0.07-0.27), 5% for Y-stents (95% CI = -0.03-0.12), and 13% for FDS (95% CI = -0.01-0.27). Meta-regression indicated larger aneurysms had higher complication rates (P = 0.02). Thromboembolic events were most frequent with FDS and Y-stents(12%).
    CONCLUSIONS: Occlusion rates were similar across treatments, but recurrence rates were significantly lower after Y-stents and FDS compared to primary coiling, although they carried a higher number of thromboembolic complications.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号